Tennessee Oncology Chattanooga-SCRI is a clinical research site located in Chattanooga, Tennessee, United States 37404.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Tennessee Oncology Chattanooga-SCRI has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms.
Sponsors: Eli Lilly and Company.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Tennessee Oncology Chattanooga-SCRI has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Tennessee Oncology Chattanooga-SCRI has 1 clinical trials on record, with 1 currently active. Their work covers Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms.
Tennessee Oncology Chattanooga-SCRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.